...Health info at your doorstep

Day: 17 November 2020

$60 Experimental COVID-19 Vaccine Rolled out in China

$60 Experimental COVID-19 Vaccine Rolled out in China

NEWS
A $60 double-dose experimental COVID-19 vaccine is being made available to some residents in an eastern Chinese city, health officials have said, the first details of a mass rollout for an as-yet unproven vaccine. Officials in Jiaxing city said on Thursday that residents aged between 18 and 59 with “urgent needs” can seek consultations at clinics for a Sinovac Biotech vaccine that authorities have been giving to groups such as medical workers. The statement from Jiaxing’s centre for disease control and prevention, however, did not specify what constituted “urgent needs”. Authorities did not say how many people in the city had been given the vaccine, which comes in two doses, administered up to 28 days apart and costing a total of 400 yuan ($59). China has alre
Pfizer and BioNtech COVID-19 Vaccine sets the World in Comfort Mood

Pfizer and BioNtech COVID-19 Vaccine sets the World in Comfort Mood

Cover Stories, NEWS
After over eight months of COVID-19 induced trepidation across the world, humanity can now heave a sigh of relief as global pharmaceutical giants Pfizer and BioNTech announced on November 9 a major breakthrough in vaccine candidate against the deadly disease. The announcement provoked instantaneous waves of reactions from world leaders, scientists, and health experts though with a mixture of sentiments. United States President Donald Trump welcomed the development in an all caps tweet declaring “STOCK MARKET UP BIG, VACCINE IS COMING.”  “SUCH GREAT NEWS!” The vaccine breakthrough coincides with Trump’s assurances in September during a White House Press Briefing that a vaccine for effective prevention of the virus would be approved late October. Meanwhile, United States President-elect,
Making CBN’s Credit Support Fund Work

Making CBN’s Credit Support Fund Work

Editorial Opinion, NEWS
Recent reports affirming the receipt of the Central Bank of Nigeria credit support facility by a number of pharmaceutical industry operators raises the hope of a brighter future for the critical sector of the nation’s economy.  As at the last count about 15 operators have so far accessed the facility while another 15 are currently waiting for the apex bank’s approvals. The reports have also put paid to earlier speculations that the intervention may go the way of many developmental initiatives inaugurated by government that never went beyond paper work. CBN deserves commendation for the commitment in rolling the policy off the ground. As part of proactive measures to cushion the negative impact of coronavirus pandemic, the CBN had in March introduced a N100 billion credit support interven